Paragon Capital Management LTD Becton Dickinson & CO Transaction History

Paragon Capital Management LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$218.29 - $256.91 $1,746 - $2,055	-8 Reduced 0.57%	1,393 $0
Q3 2022 Oct 14, 2022	SELL	$51.03 - $264.23 $51 - $264	-1 Reduced 0.07%	1,401 $312,000
Q1 2022 Apr 19, 2022	BUY	$243.64 - $270.48 $243 - $270	1 Added 0.07%	1,402 $373,000
Q2 2020 Jul 27, 2020	BUY	$219.9 - $263.41 $308,079 - $369,037	1,401 New	1,401 $335,000
Q1 2020 Apr 29, 2020	SELL	$195.69 - $279.01 $274,161 - $390,893	-1,401 Closed	0 $0
Q2 2019 Jul 23, 2019	SELL	$217.4 - $246.08 $28,044 - $31,744	-129 Reduced 8.43%	1,401 $353,000
Q4 2018 Jan 29, 2019	SELL	$204.73 - $257.93 $3,889 - $4,900	-19 Reduced 1.23%	1,530 $345,000
Q1 2018 Apr 24, 2018	SELL	$205.46 - $240.27 $7,191 - $8,409	-35 Reduced 2.21%	1,549 $336,000
Q3 2017 Oct 26, 2017	BUY	$186.89 - $198.9 $296,033 - $315,057	1,584	1,584 $310,000

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Paragon Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Paragon Capital Management LTD with notifications on news.